iShares U.S. Medical Devices ETF (IHI)
| Assets | $4.91B |
| Expense Ratio | 0.40% |
| PE Ratio | 38.24 |
| Shares Out | 81.65M |
| Dividend (ttm) | $0.26 |
| Dividend Yield | 0.44% |
| Ex-Dividend Date | Sep 25, 2024 |
| Payout Ratio | 16.65% |
| 1-Year Return | +23.18% |
| Volume | 376,881 |
| Open | 59.90 |
| Previous Close | 59.96 |
| Day's Range | 59.47 - 59.97 |
| 52-Week Low | 49.47 |
| 52-Week High | 60.88 |
| Beta | 0.90 |
| Holdings | 53 |
| Inception Date | May 1, 2006 |
About IHI
Fund Home PageThe iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select / Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is issued by BlackRock.
Top 10 Holdings
73.50% of assets| Name | Symbol | Weight |
|---|---|---|
| Abbott Laboratories | ABT | 16.82% |
| Intuitive Surgical, Inc. | ISRG | 15.61% |
| Stryker Corporation | SYK | 11.15% |
| Boston Scientific Corporation | BSX | 4.67% |
| Edwards Lifesciences Corporation | EW | 4.42% |
| GE HealthCare Technologies Inc. | GEHC | 4.38% |
| Medtronic plc | MDT | 4.31% |
| Becton, Dickinson and Company | BDX | 4.29% |
| ResMed Inc. | RMD | 4.04% |
| IDEXX Laboratories, Inc. | IDXX | 3.82% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 25, 2024 | $0.080 | Sep 30, 2024 |
| Jun 11, 2024 | $0.053 | Jun 17, 2024 |
| Mar 21, 2024 | $0.031 | Mar 27, 2024 |
| Dec 20, 2023 | $0.097 | Dec 27, 2023 |
| Sep 26, 2023 | $0.116 | Oct 2, 2023 |
| Jun 7, 2023 | $0.053 | Jun 13, 2023 |
News
Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI
The Investment Committee give you their top stocks to watch for the second half.
IHI: A Pricey P/E But Bullish Chart Setup
Health Care sector at 52-week highs, led by Eli Lilly. Hold rating on iShares U.S. Medical Devices ETF (IHI) due to high valuation and secular headwinds. IHI has strong chart setup but high valuation,...
IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued
iShares U.S. Medical Devices ETF has underperformed in recent times. The healthcare sector is considered defensive, but medical devices may still be sensitive to economic downturns. IHI's present valu...
IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors
BOSTON--(BUSINESS WIRE)-- #IHIForum--The Institute for Healthcare Improvement (IHI) has announced that Susan Ehrlich, MD, MPP, has joined its Board of Directors.
IHI Lucian Leape Institute Releases Artificial Intelligence (AI) Recommendations for Patient Safety and Health System Leaders
BOSTON & ORLANDO, Fla.--(BUSINESS WIRE)-- #IHIForum--The IHI Lucian Leape Institute (LLI) today released, “Patient Safety and Artificial Intelligence: Opportunities and Challenges for Care Delivery.”.
IHI and The DAISY Foundation™ Honor Extraordinary Nurses in Patient Safety
BOSTON--(BUSINESS WIRE)-- #daisyaward--The Institute for Healthcare Improvement (IHI) and The DAISY Foundation have announced the recipients of the 10th annual DAISY Award®.
IHI Launches First Collaborative to Accelerate System-Wide Spread of Age-Friendly Care for Older Adults
BOSTON--(BUSINESS WIRE)-- #AFHS--The Institute for Healthcare Improvement has launched an Age-Friendly System-Wide Spread Collaborative, engaging 30 health systems across the US.
IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF
iShares U.S. Medical Devices ETF has demonstrated the greatest long-term performance among peer funds and is uniquely postured for growth looking forward given its mix of top holdings. Abbott Laborato...
IHI: High Valuation But Growing Healthcare Play
Investing in medical device stocks can be a compelling option due to the growing industry, high demand, and technological advancements. The iShares U.S. Medical Devices ETF provides broad exposure to ...
IHI: Nibbling Again On Attractive Healthcare Sector Valuation
The healthcare sector has underperformed but shows signs of improvement. Non-pharma industries may offer better value in the long term.
The FDA Crash - Are Regulations Killing The Bull Case For Medical Devices And IHI?
FDA announcement of the creation of a Digital Health Advisory Committee causes a 7.2% decline in the iShares U.S. Medical Devices ETF. Digital health industry shows immense potential, driven by consum...
IHI: Too Expensive Considering Long-Term Rate Uncertainty
It appears that the performance of iShares U.S. Medical Devices ETF isn't taking into account any expectations of long-term rates in bond markets. Long-term rates have an outsized impact on stocks who...
IHI: Larger Healthcare Equipment Companies Are At An Advantage
The top 10 companies of IHI account for a large majority of 71% of its total holdings and have a slightly stronger outlook this year supported by stronger average management guidance. The top IHI comp...
IHI: Valuation Still Rich Despite The Decline In 2022
IHI invests in large-cap medical devices stocks in the United States. The fund has a long run way of growth thanks to long-term growth trends in the medical devices industry.
IHI Is Just So Expensive
Something about medical devices seems to encourage huge premiums on the multiples. Thermo Fisher and Abbott Labs are still dealing with the substantial come-down of their COVID-19 supported revenue.
IHI Forum Convenes With Call to Action for a System-Wide Approach to Health Equity
BOSTON & ORLANDO, Fla.--(BUSINESS WIRE)--Dr. Kedar Mate, President and CEO of the Institute for Healthcare Improvement (IHI), kicked-off the IHI Forum 2022 today by calling for collective action to ...
IYH And IHI ETFs: These 2 Healthcare/Medical Funds Compliment Each Other
The iShares U.S. Healthcare ETF (IYH) seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities. The iShares U.S. Medical Devices ETF (IH...
What The Inflation Reduction Act Means For Drug Prices
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs ...
IHI Can Boast Of Secular Growth, But Abbott Hinders Resilience
Thinking more about ETF options for the pandemic, one might consider something like medical devices. Medical devices often have interesting economics, namely high barriers to entry once MDs become com...
IHI: Poor Price Performance May Be Temporary
Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical D...
IHI: A Standout Performer With Equally Strong Future Growth Prospects
IHI is one of the rare healthcare ETF to outperform S&P 500.
IHI: Medical Device Stocks Are Probably Overvalued
IHI recently saw significant inflows. However, while IHI is finding some recent support near all-time highs, I think the positive sentiment has some room to unwind.